Research Paper Volume 15, Issue 19 pp 10640—10680
Multi-omics analysis of MRPL-13 as a tumor-promoting marker from pan-cancer to lung adenocarcinoma
Figure 2. AUC of ROC curves verified the diagnosis performance of MRPL13 in the TCGA cohort. (A) ROC curve shows the value of MRPL13 in the diagnosis of patients with Pan-cancer, including UCEC, THCA, STAD, LUSC, LUAD, LIHC, KIRC, KICH, ESCA, CHOL, BRCA, BLCA, HNSC. (B) Venn diagram showed the intersection of cancer in pan-cancer, which was significant in expression, diagnostic performance and prognosis analysis.